Avastin/Lucentis/Eylea ruling good news for patients, says RPS

Responding to news that the NHS will allow Avastin to be prescribed for age related wet macular degeneration, RPS President Ash Soni said:“This is a landmark ruling and good news for patients
Source: Royal Pharmaceutical Society News - Category: Drugs & Pharmacology Source Type: news